-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Cullinan Therapeutics, Inc. quarterly/annual Deferred Income Tax Expense (Benefit) history and change rate from 2020 to 2024.
- Cullinan Therapeutics, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending 31 Mar 2023 was $0.000.
- Cullinan Therapeutics, Inc. annual Deferred Income Tax Expense (Benefit) for 2024 was $3M, a 44.4% decline from 2023.
- Cullinan Therapeutics, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was $5.4M.
- Cullinan Therapeutics, Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was $0.000.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Change (%)